A61P 35 - Antineoplastic agents

Patents for A61P 35 - Antineoplastic agents (221,099)
11/2009
11/25/2009	CN101584817A Traditional Chinese medicine for treating urinary calculus and tumor
11/25/2009	CN101584804A Chinese medicament for treating cancer bronchio-pulmonaire
11/25/2009	CN101584802A Chinese medicinal capsule for treating malignant lymphoma
11/25/2009	CN101584801A Traditional Chinese medicine for treating primary lung cancer
11/25/2009	CN101584776A Cordyceps P.E. nutrition capsule
11/25/2009	CN101584718A Antisepalous kiwi fruit leaf extractive as well as preparation method and application thereof
11/25/2009	CN101584698A 6H-thiochromeno[4, 3-d][1, 2, 4]triazolo[1, 5-a] pyrimidine serial synthetic medicine with anticancer activity
11/25/2009	CN101584697A 6H-thiochromeno[3, 4-e][1, 2, 4]triazolo[1, 5-a] pyrimidine compounds with anticancer activity
11/25/2009	CN101584696A Composition containing quinazoline derivatives, preparation method and use
11/25/2009	CN101584690A 2, 3, 3a, 4-tetrahydrothiochromeno2H-pyrazole serial compound with anticancer activity
11/25/2009	CN101584679A Novel oral capsule preparation for treating cancer and AIDS
11/25/2009	CN101584672A Clofarabine pharmaceutical composition freeze-dried powder injection and preparation method thereof
11/25/2009	CN101584669A Melphalan freeze-dried powder injection
11/25/2009	CN101584668A Bendamustine hydrochloride freeze-dried powder injection
11/25/2009	CN101584663A Novel delivery system of Duoxitasai lipidosome for injection and preparation method thereof
11/25/2009	CN101584662A Etoposide lipidosome and preparation method thereof
11/25/2009	CN101584661A Preparation of sorafenib self-microemulsifying drug delivery system for oral administration or intravenous injection and use thereof
11/25/2009	CN101584660A Intravenous injection perilla alcohol submicron emulsion and preparation method thereof
11/25/2009	CN101584659A Docetaxel medicament composition injection and preparation method thereof
11/25/2009	CN100562570C Modified recombinant vaccinia viruses and other microorganisms, uses thereof
11/25/2009	CN100562518C Novel arylethene-sulfonamides compounds
11/25/2009	CN100562341C Application of cell nucleus targeting chitosan-fatty acid graft as medicine carrier micelle
11/25/2009	CN100562325C Composition of Chinese traditional medicine for treating tumor, and preparation method
11/25/2009	CN100562323C Combination of medication for treating hysteromycoma and preparation method
11/25/2009	CN100562321C Application of diosgenin in preparing medicine with synergistic attenuation
11/25/2009	CN100562318C Process for producing crystal
11/25/2009	CN100562316C Cis-imidazolines as MDM2 inhibitors
11/25/2009	CN100562311C Cisplatin preparation method and its application method
11/24/2009	US7622612 Tricyclic derivatives and their use
11/24/2009	US7622556 Modified cytokines for use in cancer therapy
11/24/2009	US7622494 Chemical compounds
11/24/2009	US7622479 For example, 2-(1,3-benzodioxol-5-yl)-6-phenyl-1H-imidazo[4,5-b]pyridinetyrosine; kinase-inhibiting activity; use in treatment of breast cancer, prostate cancer, lung cancer or pancreatic carcinoma
11/24/2009	US7622477 inhibiting the neointimal growth of vasculature after catheter and balloon intervention; new isomers and 42-epimers of rapamycin alkyl ether analogs may also possess better stability in a formulation
11/24/2009	US7622472 Combination of Src kinase inhibitors and chemotherapeutic agents for the treatment of proliferative diseases
11/24/2009	US7622457 Polynucleotides encoding anticoagulant fusion proteins
11/24/2009	US7622272 Treating cell proliferation disease; aberrant fetoplacental growth; cancer
11/24/2009	US7622122 Oxidative damage and protease activity resistance; catalytic efficiency; deep vein thrombosis, disseminated intravascular coagulation, acute coronary syndrome; targeting protein, that interacts with tissue factor or the factor VIIa/tissue factor complex
11/24/2009	US7622119 Wilm's tumor amino acid sequences for use as tissue targeted agent for treatment of cell proliferative disorders
11/24/2009	US7622115 Treatment with anti-VEGF antibodies
11/24/2009	US7622105 Conjugation product of a cytokine selected from tumor necrosis factor and interferon gamma and a ligand of CD13 receptor; antitumor agents
11/24/2009	CA2552786C Crystalline polymorph of a bisulfate salt of a thrombin receptor antagonist
11/24/2009	CA2493336C Composition for solubilization of paclitaxel and preparation method thereof
11/24/2009	CA2475712C Nicotinamide derivatives useful as pde4 inhibitors
11/24/2009	CA2434381C Naphthostyrils
11/24/2009	CA2423384C New cross-linked derivatives of hyaluronic acid
11/24/2009	CA2421504C 2-amino-2-alkyl-5 heptenoic and heptynoic acid derivatives useful as nitric oxide synthase inhibitors
11/24/2009	CA2343120C Use of an anthracycline derivative for the treatment of a liver tumor
11/24/2009	CA2303063C Mage-3 peptides presented by hla class ii molecules
11/24/2009	CA2203182C Remedy for diseases caused by il-6 production
11/24/2009	CA2201105C Inhibitor of stem cell proliferation and uses thereof
11/19/2009	WO2009140675A2 Combination therapy with an antitumor alkaloid
11/19/2009	WO2009140599A1 Treatment of metastatic tumors
11/19/2009	WO2009140553A2 Hypoxia activated drugs of nitrogen mustard alkylators
11/19/2009	WO2009140549A1 Combinations vegf(r) inhibitors and hepatocyte growth factor (c-met) inhibitors for the treatment of cancer
11/19/2009	WO2009140326A2 Microfluidic isolation of tumor cells or other rare cells from whole blood or other liquids
11/19/2009	WO2009140320A1 Pyrrolopyridines as kinase inhibitors
11/19/2009	WO2009140287A1 Salinosporamide derivatives as proteasome inhibitors
11/19/2009	WO2009140131A2 Compliant composites for application of drug-eluting coatings to tissue surfaces
11/19/2009	WO2009140124A1 Anti-cxcr4 antibodies
11/19/2009	WO2009140101A2 Imidazopyridine compounds useful as mmp-13 inhibitors
11/19/2009	WO2009139972A2 Site specific fluorescence marking and contrast marker for same
11/19/2009	WO2009139921A2 Microorganisms for preventing and treating neoplasms accompanying cellular therapy
11/19/2009	WO2009139916A1 Tricyclic triazole compounds that modulate hsp90 activity
11/19/2009	WO2009139891A2 Antagonists of bmp9, bmp10, alk1 and other alk1 ligands, and uses thereof
11/19/2009	WO2009139880A1 Thioxoisoindoline compounds and compositions and methods of using the same
11/19/2009	WO2009139766A1 Anticancer combination therapy including triciribine
11/19/2009	WO2009139599A2 Cell-permeable p27 recombinant protein, a polynucleotide that codes the same and an anti-cancer composition containing the same as an active ingredient
11/19/2009	WO2009139373A1 Amide compound
11/19/2009	WO2009139361A1 Glucocorticoid receptor agonist composed of 2,2,4-trimethyl-6-phenyl-1,2-dihydroquinoline derivative having substituted oxy group
11/19/2009	WO2009139343A1 Antitumor agent, kit and method of treating cancer
11/19/2009	WO2009139298A1 Metastin derivative and use thereof
11/19/2009	WO2009139085A1 Antitumor agent, kit, and method for treating cancer
11/19/2009	WO2009138860A1 Plant extract and its therapeutic use
11/19/2009	WO2009138799A1 Therapeutic uses of 1-cycl0pr0pyl-3 - [3- ( 5 -morpholin- 4 -ylmethyl- 1h-benz0imidaz0l- 2 -yl) -lh-pyrazol-4-yl] -urea
11/19/2009	WO2009138790A1 Substituted quinazolines and their uses for myeoloprolific and thrombotic diseases
11/19/2009	WO2009138781A1 Fumarate salt of 4- (3-chloro-2-fluoroanilino) -7-methoxy-6- { [1- (n-methylcarbamoylmethyl) piperidin- 4-yl] oxy}quinazoline
11/19/2009	WO2009138780A2 Therapeutic treatment - 355
11/19/2009	WO2009138779A1 Combination comprising 4- (3-chloro-2-fluoroanilino) -7-meth0xy-6- { [1- (n-methylcarbamoylmethyl) piperidin- 4-yl] oxyjquinazoline
11/19/2009	WO2009138762A2 Therapeutic use of peptides
11/19/2009	WO2009138542A1 Use of hsp90 protein inhibiting compounds and pharmaceutical composition intended for anti-tumour therapy
11/19/2009	WO2009138519A1 AMINO ACID SEQUENCES DIRECTED AGAINST CXCR4 AND OTHER GPCRs AND COMPOUNDS COMPRISING THE SAME
11/19/2009	WO2009138509A1 Multiple myeloma treatments
11/19/2009	WO2009138440A1 Carbamoyl derivatives of bicyclic carbonylamino-pyrazoles as prodrugs
11/19/2009	WO2009138396A2 Conjugates for the treatment of mesothelioma
11/19/2009	WO2009138338A1 Novel n-(2-amino-phenyl)-acrylamides
11/19/2009	WO2009138094A1 Pharmaceutical compositions
11/19/2009	WO2009137871A1 Methods of detecting cells with a disrupted cell membrane, cells infected with a pathogen, dying cells or dead cells
11/19/2009	WO2009118475A3 Platinum-n-heterocyclic carbene derivatives, preparation thereof and therapeutic use thereof
11/19/2009	WO2009118473A3 Azetidine-derived compounds, preparation method therefor and therapeutic use of same
11/19/2009	WO2009114856A3 Aurora kinase inhibitors
11/19/2009	WO2009112550A4 Novel n-substituted tetrahydroisoquinoline/isoindoline hydroxamic acid compounds
11/19/2009	WO2009108932A3 Selectin ligands useful in the diagnosis and treatment of cancer
11/19/2009	WO2009105238A3 Kinase protein binding inhibitors
11/19/2009	WO2009105230A3 Methods for treating cancer using combination therapy
11/19/2009	WO2009102880A3 Structure and bioactivity of the polysaccharides and oligomers in medicinal plant dendrobium huoshanense
11/19/2009	WO2009089537A3 Anti-cancer compounds
11/19/2009	WO2009077586A3 Methods and compositions for the preparation and use of toxin conjugates
11/19/2009	WO2009074300A8 Hedgehog pathway antagonists and therapeutic applications thereof
11/19/2009	WO2009055613A3 Inhibition of urokinase-type plasminogen activator (upa) activity
11/19/2009	WO2009046220A3 Lipopeptides for delivery of nucleic acids

1 ... 753 754 755 756 757 758 759 760 761 762 763 764 765 766 767 768 769 770 771 772 773 ... 2211